In 2012, SIAPS supported the Directorate General of Family Planning (DGFP) in conducting a five-year (2012-2016) forecasting exercise for reproductive health commodities and built the technical capacity of DGFP officials to manage the forecasting processes and analyze the FP2020 indicators pertinent to stock availability. SIAPS also assisted DGFP in forming the multi-stakeholder Forecasting Working Group (FWG) to annually review needs and facilitate data-informed procurement decisions. The FWG uses data collected through information management platforms and conducts quantification exercises on the basis of the consumption of RH/FP commodities. The 2012 forecasting exercise helped DGFP avoid redundant procurement decisions by using good-quality logistics data and saved money. However, after 2016, it had to be updated with the latest data. Therefore, at USAID’s request, SIAPS worked with FWG and developed another five-year (2017-2021) forecast of RH commodities to enable evidence-based contraceptive procurement decisions. The goal is to optimize a data driven procurement system and minimize losses through expiry from overstocking.
Archive | Family Planning and Reproductive HealthRSS feed for this section
To learn more about SIAPS program activities worldwide, please read our annual report for program year 5.
This guide provides national stakeholders and advocates with information and guidance to update the national EML to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, timeline, and process may vary from country to country, this guide presents the broad steps involved in revising an EML for any health commodity. Additional resources and a glossary are included to provide supplemental information and to clarify key terms.
The UN Commission on Life-Saving Commodities (UNCoLSC) Supply Chain Technical Resource Team developed a quantification supplement covering 13 underused reproductive, maternal, newborn, and child health commodities with great lifesaving potential. These 13 commodities, prioritized by the UNCoLSC, have diverse characteristics: some are new products in the process of being introduced, while others have been in […]
Guidance for Planning the Introduction of New Reproductive, Maternal, Newborn, and Child Health Medicines and Supplies
The purpose of this document is to provide guidance to program managers in ministries of health at national and sub-national levels as well as personnel in other interested organizations on actions to take and factors to consider when expanding access to essential RMNCH commodities. While this document focuses on RMNCH medicines and supplies, it may be used as a guiding document and planning tool for other essential medicines and supplies. This guide addresses several pharmaceutical management issues (pharmaceutical policies, effective medicine management, strengthening regulatory systems, information needs, and product quality and safety practices) that are often overlooked when considering the introduction of new products. The systems strengthening approach described in this document focuses on governance, human resources, information systems, financing, and service delivery, with the provision of medical products cutting across these sub-systems. The goal of this guidance document is to assist managers to systematically plan for the successful introduction of new medicines and supplies by harmonizing and aligning efforts among all stakeholders involved in the process.
Analysis of Bottlenecks Related to Demand, Supply, and Use of Antibiotics for the Treatment of Neonatal Sepsis in the DRC
This study was initiated by the Direction de la Santé de la Famille et de Groupes Spécifiques (D10) and the Ministry of Public Health and carried out with technical and financial assistance from the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) and Integrated Health Project (PROSANI-Plus) implemented by Management Sciences for Health (MSH). The study stems from the many efforts by the Government and its partners to reduce maternal, infant, and, specifically, neonatal mortality.
Funding for the study, the report, and its dissemination was obtained from the Global Technical Reference Team for injectable antibiotics through the convener of the group, Save the Children.
Ghoneim R, Feinberg J. Increasing Access to Lifesaving Commodities for Women and Children: Getting the Numbers Right. This seminar was presented as part of the 2016 USAID Global Health Mini-University. For more information on the Mini-University, visit www.mini-university.com.
For the first time in the Democratic Republic of the Congo (DRC), 13 life-saving health commodities for mothers and children have been included in the National Health Development Plan (NHDP). These medicines are recommended by the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC). The move by the Ministry of Public Health […]
Health Facility Assessment on Availability of the 13 Reproductive, Maternal, Newborn, and Child Health Commodities Prioritized by the UN Commission on Life-Saving Commodities for Women and Children
Every day, about 800 women die from preventable causes related to pregnancy and childbirth. Although great strides have been made in reducing global child mortality, newborns now account for 44% of all childhood deaths. Ethiopia contributes to more than 4% of all global maternal deaths, which were estimated at 1,300 in 2013. In 2010, the UN Secretary-General’s Global Strategy for Women’s and Children’s Health highlighted the suffering of women and children around the world caused by lack of access to life-saving commodities. With a strong focus on the reproductive, maternal, newborn, and child health (RMNCH) continuum of care, the UN Commission on Life-Saving Commodities for Women and Children (UNCoLSC), identified and endorsed an initial list of 13 life-saving commodities that, if more widely accessed and properly used, could save the lives of more than 6 million women and children.
As part of examining the current status and empowering Drug and Therapeutics Committees (DTCs) to continually monitor availability of priority RMNCH (UN life-saving) medicines, a baseline assessment was conducted July 27–31, 2015, at selected health facilities in Ethiopia. The information generated from this assessment is expected to help guide future interventions needed in relation to strengthening health facility DTCs to monitor and ensure availability of these life-saving medicines on a continuous basis.
The Maternal Health Technical Resource Team (MHTRT) of the UN Commission on Life-Saving Commodities for Women and Children has been exploring strategies to increase access to quality oxytocin, including advocating for the integration of oxytocin in the existing cold chain for the Expanded Programme on Immunization (EPI).
Some countries, such as Mali and Ghana, have attempted integration in some areas of the country already and have experiences that can help answer that question. PATH and the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program recently prepared case studies on these countries that describe the extent to which integration was achieved. In neither case was integration systematic; it occurred spontaneously and out of necessity at points along the distribution chain.
The purpose of this activity is to work with national stakeholders to identify and analyze feasible and acceptable options for the integration of oxytocin in the EPI cold chain at key points along the distribution chain and to develop guidance on the operationalization of such integration.
A team composed of an international consultant, a national consultant, two representatives from the Directorate of Pharmacy and Medicines (DPM) and the SIAPS-Mali team worked together in the preparation and organization of workshops.
During the preparatory phase of the two working meetings, the team developed the terms of reference, the letter of invitation, and the agenda of the working meetings and presentations and agreed on the profile of the participants for the working meetings.
The methodological approach was the same for both working meetings, namely presentations followed by discussion and group work, summarized in a plenary session.
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Project dates: January 2012 – September 2017
- What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening
SIAPS is presenting its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening” on […]